{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:46:32Z","timestamp":1782351992012,"version":"3.54.5"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#82271071"],"award-info":[{"award-number":["#82271071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81970787"],"award-info":[{"award-number":["#81970787"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#81770910"],"award-info":[{"award-number":["#81770910"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#82371039"],"award-info":[{"award-number":["#82371039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["#2019B1515120014"],"award-info":[{"award-number":["#2019B1515120014"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"DOI":"10.1038\/s41418-026-01789-4","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:27:52Z","timestamp":1782343672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of Pax6 sumoylation suppresses the tumorigenicity of pancreatic cancer cells"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4518-2853","authenticated-orcid":false,"given":"Yuan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-0144","authenticated-orcid":false,"given":"Mi","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Miao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Bin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7398-7630","authenticated-orcid":false,"given":"David Wan-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"1789_CR1","first-page":"36","volume":"39","author":"H Ying","year":"2025","unstructured":"Ying H, Kimmelman AC, Bardeesy N, Kalluri R, Maitra A, DePinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2025;39:36\u201363.","journal-title":"Genes Dev"},{"key":"1789_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"1789_CR3","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, Bouch\u00e9 O, Guimbaud R, B\u00e9couarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817\u201325.","journal-title":"N Engl J Med"},{"key":"1789_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-018-0088-0","volume":"557","author":"Q Zhou","year":"2018","unstructured":"Zhou Q, Melton DA. Pancreas regeneration. Nature. 2018;557:351\u20138.","journal-title":"Nature"},{"key":"1789_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ccr.2013.03.008","volume":"23","author":"H Han","year":"2013","unstructured":"Han H, Von Hoff DD. SnapShot: pancreatic cancer. Cancer Cell. 2013;23:424\u2013424.e1.","journal-title":"Cancer Cell"},{"key":"1789_CR6","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"1789_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00535-019-01620-7","volume":"55","author":"Y Eso","year":"2020","unstructured":"Eso Y, Shimizu T, Takeda H, Takai A, Marusawa H. Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers. J Gastroenterol. 2020;55:15\u201326.","journal-title":"J Gastroenterol"},{"key":"1789_CR8","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, et al. Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol. 2019;5:1431\u20138.","journal-title":"JAMA Oncol"},{"key":"1789_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0888-7543(92)90239-O","volume":"13","author":"CC Ton","year":"1992","unstructured":"Ton CC, Miwa H, Saunders GF. Small eye (Sey): cloning and characterization of the murine homolog of the human aniridia gene. Genomics. 1992;13:251\u20136.","journal-title":"Genomics"},{"key":"1789_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ng1192-232","volume":"2","author":"T Glaser","year":"1992","unstructured":"Glaser T, Walton DS, Maas RL. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat Genet. 1992;2:232\u20139.","journal-title":"Nat Genet"},{"key":"1789_CR11","first-page":"7257","volume":"13","author":"C Carriere","year":"1993","unstructured":"Carriere C, Plaza S, Martin P, Quatannens B, Bailly M, Stehelin D, et al. Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the neuroretina. Mol Cell Biol. 1993;13:7257\u201366.","journal-title":"Mol Cell Biol"},{"key":"1789_CR12","doi-asserted-by":"publisher","first-page":"8355","DOI":"10.1016\/S0021-9258(17)37201-0","volume":"269","author":"J Epstein","year":"1994","unstructured":"Epstein J, Cai J, Glaser T, Jepeal L, Maas R. Identification of a Pax paired domain recognition sequence and evidence for DNA-dependent conformational changes. J Biol Chem. 1994;269:8355\u201361.","journal-title":"J Biol Chem"},{"key":"1789_CR13","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1101\/gad.471708","volume":"22","author":"TC Tuoc","year":"2008","unstructured":"Tuoc TC, Stoykova A. Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system. Genes Dev. 2008;22:1972\u201386.","journal-title":"Genes Dev"},{"key":"1789_CR14","doi-asserted-by":"publisher","first-page":"15115","DOI":"10.1074\/jbc.274.21.15115","volume":"274","author":"I Mikkola","year":"1999","unstructured":"Mikkola I, Bruun JA, Bjorkoy G, Holm T, Johansen T. Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem. 1999;274:15115\u201326.","journal-title":"J Biol Chem"},{"key":"1789_CR15","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1074\/jbc.M507227200","volume":"281","author":"EA Kim","year":"2006","unstructured":"Kim EA, Noh YT, Ryu MJ, Kim HT, Lee SE, Kim CH, et al. Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2. J Biol Chem. 2006;281:7489\u201397.","journal-title":"J Biol Chem"},{"key":"1789_CR16","doi-asserted-by":"publisher","first-page":"13954","DOI":"10.1074\/jbc.M611476200","volume":"282","author":"Q Yan","year":"2007","unstructured":"Yan Q, Liu WB, Qin J, Liu J, Chen HG, Huang X, et al. Protein phosphatase-1 modulates the function of Pax-6, a transcription factor controlling brain and eye development. J Biol Chem. 2007;282:13954\u201365.","journal-title":"J Biol Chem"},{"key":"1789_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ydbio.2003.09.011","volume":"265","author":"DA Kleinjan","year":"2004","unstructured":"Kleinjan DA, Seawright A, Childs AJ, van Heyningen V. Conserved elements in Pax6 intron 7 involved in (auto)regulation and alternative transcription. Dev Biol. 2004;265:462\u201377.","journal-title":"Dev Biol"},{"key":"1789_CR18","doi-asserted-by":"publisher","first-page":"21034","DOI":"10.1073\/pnas.1007866107","volume":"107","author":"Q Yan","year":"2010","unstructured":"Yan Q, Gong L, Deng M, Zhang L, Sun S, Liu J, et al. Sumoylation activates the transcriptional activity of Pax-6, an important transcription factor for eye and brain development. Proc Natl Acad Sci USA. 2010;107:21034\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1789_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.neuron.2008.12.006","volume":"61","author":"A Onishi","year":"2009","unstructured":"Onishi A, Peng GH, Hsu C. Pias3-dependent SUMOylation directs rod photoreceptor development. Neuron. 2009;61:234\u201346.","journal-title":"Neuron"},{"key":"1789_CR20","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/nn.2618","volume":"13","author":"A Onishi","year":"2010","unstructured":"Onishi A, Peng GH, Chen S, Blackshaw S. Pias3-dependent SUMOylation controls mammalian cone photoreceptor differentiation. Nat Neurosci. 2010;13:1059\u201365.","journal-title":"Nat Neurosci"},{"key":"1789_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1591-4","volume":"10","author":"DM Wu","year":"2019","unstructured":"Wu DM, Zhang T, Liu YB, Deng SH, Han R, Liu T, et al. The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K\/AKT signaling. Cell Death Dis. 2019;10:349.","journal-title":"Cell Death Dis"},{"key":"1789_CR22","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1038\/s41388-018-0373-2","volume":"37","author":"A Ooki","year":"2018","unstructured":"Ooki A, Dinalankara W, Marchionni L, Tsay JJ, Goparaju C, Maleki Z, et al. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Oncogene. 2018;37:5967\u201381.","journal-title":"Oncogene"},{"key":"1789_CR23","first-page":"3369","volume":"9","author":"YH Zhou","year":"2003","unstructured":"Zhou YH, Tan F, Hess KR, Yung WK. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clin Cancer Res. 2003;9:3369\u201375.","journal-title":"Clin Cancer Res"},{"key":"1789_CR24","first-page":"1860","volume":"25","author":"C Hao","year":"2020","unstructured":"Hao C, Gao C, Shang H, Liu J, Qi F. MicroRNA-31 inhibits the growth and metastasis and enhances drug sensitivity of the human colon cancer cells by targeting PAX6. J BUON. 2020;25:1860\u20135.","journal-title":"J BUON"},{"key":"1789_CR25","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0801119","volume":"359","author":"JC Han","year":"2008","unstructured":"Han JC, Liu QR, Jones M, Levinn RL, Menzie CM, Jefferson-George KS, et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359:918\u201327.","journal-title":"N Engl J Med"},{"key":"1789_CR26","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2016.10.039","volume":"167","author":"B Hu","year":"2016","unstructured":"Hu B, Wang Q, Wang YA, Hua S, Sauv\u00e9 CG, Ong D, et al. Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell. 2016;167:1281\u20131295.e18.","journal-title":"Cell"},{"key":"1789_CR27","doi-asserted-by":"publisher","first-page":"27524","DOI":"10.1074\/jbc.M109.047209","volume":"284","author":"JB Mascarenhas","year":"2009","unstructured":"Mascarenhas JB, Young KP, Littlejohn EL, Yoo BK, Salgia R, Lang D. PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene. J Biol Chem. 2009;284:27524\u201332.","journal-title":"J Biol Chem"},{"key":"1789_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/mc.20375","volume":"47","author":"D Lang","year":"2008","unstructured":"Lang D, Mascarenhas JB, Powell SK, Halegoua J, Nelson M, Ruggeri BA. PAX6 is expressed in pancreatic adenocarcinoma and is downregulated during induction of terminal differentiation. Mol Carcinog. 2008;47:148\u201356.","journal-title":"Mol Carcinog"},{"key":"1789_CR29","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrm2293","volume":"8","author":"R Geiss-Friedlander","year":"2007","unstructured":"Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007;8:947\u201356.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1789_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1146\/annurev-biochem-061909-093311","volume":"82","author":"A Flotho","year":"2013","unstructured":"Flotho A, Melchior F. Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem. 2013;82:357\u201385.","journal-title":"Annu Rev Biochem"},{"key":"1789_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/CCO.0000000000000765","volume":"33","author":"L Du","year":"2021","unstructured":"Du L, Liu W, Rosen ST. Targeting SUMOylation in cancer. Curr Opin Oncol. 2021;33:520\u20135.","journal-title":"Curr Opin Oncol"},{"key":"1789_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","volume":"7","author":"JS Kroonen","year":"2021","unstructured":"Kroonen JS, Vertegaal ACO. Targeting SUMO signaling to wrestle cancer. Trends Cancer. 2021;7:496\u2013510.","journal-title":"Trends Cancer"},{"key":"1789_CR33","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.trecan.2020.03.003","volume":"6","author":"PK Tiwari","year":"2020","unstructured":"Tiwari PK. Epigenetic biomarkers in gallbladder cancer. Trends Cancer. 2020;6:540\u20133.","journal-title":"Trends Cancer"},{"key":"1789_CR34","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1158\/0008-5472.CAN-16-2958","volume":"77","author":"A Rabellino","year":"2017","unstructured":"Rabellino A, Andreani C, Scaglioni PP. The role of PIAS SUMO E3-ligases in cancer. Cancer Res. 2017;77:1542\u20137.","journal-title":"Cancer Res"},{"key":"1789_CR35","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc.2016.143","volume":"17","author":"JS Seeler","year":"2017","unstructured":"Seeler JS, Dejean A. SUMO and the robustness of cancer. Nat Rev Cancer. 2017;17:184\u201397.","journal-title":"Nat Rev Cancer"},{"key":"1789_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.tibs.2015.09.006","volume":"40","author":"K Eifler","year":"2015","unstructured":"Eifler K, Vertegaal ACO. SUMOylation-mediated regulation of cell cycle progression and cancer. Trends Biochem Sci. 2015;40:779\u201393.","journal-title":"Trends Biochem Sci"},{"key":"1789_CR37","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ccr.2014.04.008","volume":"25","author":"MV Bogachek","year":"2014","unstructured":"Bogachek MV, Chen Y, Kulak MV, Woodfield GW, Cyr AR, Park JM, et al. Sumoylation pathway is required to maintain the basal breast cancer subtype. Cancer Cell. 2014;25:748\u201361.","journal-title":"Cancer Cell"},{"key":"1789_CR38","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ncb0608-635","volume":"10","author":"K Miyazono","year":"2008","unstructured":"Miyazono K, Kamiya Y, Miyazawa K. SUMO amplifies TGF-beta signalling. Nat Cell Biol. 2008;10:635\u20137.","journal-title":"Nat Cell Biol"},{"key":"1789_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02848-5","volume":"11","author":"F Yu","year":"2020","unstructured":"Yu F, Zhang W, Yan C, Yan D, Zhou M, Chen J, et al. PAX6, modified by SUMOylation, plays a protective role in corneal endothelial injury. Cell Death Dis. 2020;11:683.","journal-title":"Cell Death Dis"},{"key":"1789_CR40","doi-asserted-by":"publisher","first-page":"10151","DOI":"10.1111\/jcmm.15625","volume":"24","author":"P Li","year":"2020","unstructured":"Li P, Ge D, Li P, Hu F, Chu J, Chen X, et al. CXXC finger protein 4 inhibits the CDK18-ERK1\/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1\/MIR100HG pathway. J Cell Mol Med. 2020;24:10151\u201365.","journal-title":"J Cell Mol Med"},{"key":"1789_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.293","volume":"4","author":"H Lu","year":"2013","unstructured":"Lu H, Sun J, Wang F, Feng L, Ma Y, Shen, Q, et al. Enhancer of zeste homolog 2 activates WNT signaling through downregulating CXXC finger protein 4. Cell Death Dis. 2013;4:e776.","journal-title":"Cell Death Dis"},{"key":"1789_CR42","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","volume":"5","author":"RT Moon","year":"2004","unstructured":"Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5:691\u2013701.","journal-title":"Nat Rev Genet"},{"key":"1789_CR43","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/dev.01117","volume":"131","author":"X He","year":"2004","unstructured":"He X, Semenov M, Tamai K, Zeng X. LDL receptor-related proteins 5 and 6 in WNT\/beta-catenin signaling: arrows point the way. Development. 2004;131:1663\u201377.","journal-title":"Development"},{"key":"1789_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X. WNT\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9\u201326.","journal-title":"Dev Cell"},{"key":"1789_CR45","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.febslet.2014.07.014","volume":"588","author":"H Lu","year":"2014","unstructured":"Lu H, Jin W, Sun J, Feng L, Lan H, Shen Q, et al. New tumor suppressor CXXC finger protein 4 inactivates mitogen activated protein kinase signaling. FEBS Lett. 2014;588:3322\u20136.","journal-title":"FEBS Lett"},{"key":"1789_CR46","first-page":"373","volume":"26","author":"C Di","year":"2021","unstructured":"Di C, Liang J, Wang Y, Zhao G, Zhao Y. SPZ1 promotes glioma aggravation via targeting CXXC4. J BUON. 2021;26:373\u20139.","journal-title":"J BUON"},{"key":"1789_CR47","doi-asserted-by":"publisher","first-page":"BSR20180613","DOI":"10.1042\/BSR20180613","volume":"38","author":"J Lu","year":"2018","unstructured":"Lu J, Lu S, Li J, Yu Q, Liu L, Li Q. MiR-629-5p promotes colorectal cancer progression through targetting CXXC finger protein 4. Biosci Rep. 2018;38:BSR20180613.","journal-title":"Biosci Rep"},{"key":"1789_CR48","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.7150\/jca.47157","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Qiu J, He G, Geng C, He W, Liu C, et al. Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma. J Cancer. 2020;11:6288\u201398.","journal-title":"J Cancer"},{"key":"1789_CR49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","volume":"11","author":"MH Hofmann","year":"2021","unstructured":"Hofmann MH, Gmachl M, Ramharter J, Savarese F, Gerlach D, Marszalek JR, et al. BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition. Cancer Discov. 2021;11:142\u201357.","journal-title":"Cancer Discov"},{"key":"1789_CR50","doi-asserted-by":"publisher","first-page":"e2221522120","DOI":"10.1073\/pnas.2221522120","volume":"120","author":"JL Fu","year":"2023","unstructured":"Fu JL, Zheng SY, Wang Y, Hu XB, Xiao Y, Wang JM, et al. HSP90\u03b2 prevents aging-related cataract formation through regulation of the charged multivesicular body protein (CHMP4B) and p53. Proc Natl Acad Sci USA. 2023;120:e2221522120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1789_CR51","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","volume":"341","author":"D Fatkin","year":"1999","unstructured":"Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, et al. Missense mutations in the rod domain of the lamin A\/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715\u201324.","journal-title":"N Engl J Med"},{"key":"1789_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci. 2007;8:663\u201372.","journal-title":"Nat Rev Neurosci"},{"key":"1789_CR53","doi-asserted-by":"publisher","first-page":"e13222","DOI":"10.1111\/acel.13222","volume":"19","author":"FY Liu","year":"2020","unstructured":"Liu FY, Fu JL, Wang L, Nie Q, Luo Z, Hou M, et al. Molecular signature for senile and complicated cataracts derived from analysis of sumoylation enzymes and their substrates in human cataract lenses. Aging Cell. 2020;19:e13222.","journal-title":"Aging Cell"},{"key":"1789_CR54","doi-asserted-by":"publisher","first-page":"E3987","DOI":"10.1073\/pnas.1715237115","volume":"115","author":"L Gong","year":"2018","unstructured":"Gong L, Liu F, Xiong Z, Qi R, Luo Z, Gong X, et al. Heterochromatin protects retinal pigment epithelium cells from oxidative damage by silencing p53 target genes. Proc Natl Acad Sci USA. 2018;115:E3987\u2013E3995.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1789_CR55","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ncb1562","volume":"9","author":"S Carter","year":"2007","unstructured":"Carter S, Bischof O, Dejean A, Vousden KH. C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol. 2007;9:428\u201335.","journal-title":"Nat Cell Biol"},{"key":"1789_CR56","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z. Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004;4:793\u2013805.","journal-title":"Nat Rev Cancer"},{"key":"1789_CR57","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nature08593","volume":"462","author":"JR Morris","year":"2009","unstructured":"Morris JR, Boutell C, Keppler M, Densham R, Weekes D, Alamshah A, et al. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature. 2009;462:886\u201390.","journal-title":"Nature"},{"key":"1789_CR58","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.1158\/0008-5472.CAN-04-1502","volume":"64","author":"GA Smolen","year":"2004","unstructured":"Smolen GA, Vassileva MT, Wells J, Matunis MJ, Haber DA. SUMO-1 modification of the Wilms\u2019 tumor suppressor WT1. Cancer Res. 2004;64:7846\u201351.","journal-title":"Cancer Res"},{"key":"1789_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-2-39","volume":"2","author":"MP Kracklauer","year":"2003","unstructured":"Kracklauer MP, Schmidt C. At the crossroads of SUMO and NF-kappaB. Mol Cancer. 2003;2:39.","journal-title":"Mol Cancer"},{"key":"1789_CR60","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2005.09.036","volume":"123","author":"S Janssens","year":"2005","unstructured":"Janssens S, Tinel A, Lippens S, Tschopp J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell. 2005;123:1079\u201392.","journal-title":"Cell"},{"key":"1789_CR61","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ccr.2013.06.003","volume":"24","author":"MC Mulero","year":"2013","unstructured":"Mulero MC, Ferres-Marco D, Islam A, Margalef P, Pecoraro M, Toll A, et al. Chromatin-bound I\u03baB\u03b1 regulates a subset of polycomb target genes in differentiation and cancer. Cancer Cell. 2013;24:151\u201366.","journal-title":"Cancer Cell"},{"key":"1789_CR62","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1126\/science.1212728","volume":"335","author":"JD Kessler","year":"2012","unstructured":"Kessler JD, Kahle KT, Sun T, Meerbrey KL, Schlabach MR, Schmitt EM, et al. A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. Science. 2012;335:348\u201353.","journal-title":"Science"},{"key":"1789_CR63","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","volume":"131","author":"J Cheng","year":"2007","unstructured":"Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131:584\u201395.","journal-title":"Cell"},{"key":"1789_CR64","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1158\/0008-5472.CAN-12-0673","volume":"72","author":"YC Wu","year":"2012","unstructured":"Wu YC, Ling TY, Lu SH, Kuo HC, Ho HN, Yeh SD, et al. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4. Cancer Res. 2012;72:4963\u201373.","journal-title":"Cancer Res"},{"key":"1789_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1126\/science.1183424","volume":"328","author":"XW Zhang","year":"2010","unstructured":"Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, et al. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010;328:240\u20133.","journal-title":"Science"},{"key":"1789_CR66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ccr.2010.06.003","volume":"18","author":"M Jeanne","year":"2010","unstructured":"Jeanne M, Lallemand-Breitenbach V, Ferhi O, Koken M, Le Bras M, Duffort S, et al. PML\/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Cancer Cell. 2010;18:88\u201398.","journal-title":"Cancer Cell"},{"key":"1789_CR67","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1158\/0008-5472.CAN-11-3159","volume":"72","author":"A Rabellino","year":"2012","unstructured":"Rabellino A, Carter B, Konstantinidou G, Wu SY, Rimessi A, Byers LA, et al. The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA. Cancer Res. 2012;72:2275\u201384.","journal-title":"Cancer Res"},{"key":"1789_CR68","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/ncb1716","volume":"10","author":"MH Tatham","year":"2008","unstructured":"Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat Cell Biol. 2008;10:538\u201346.","journal-title":"Nat Cell Biol"},{"key":"1789_CR69","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/ncb1717","volume":"10","author":"V Lallemand-Breitenbach","year":"2008","unstructured":"Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, et al. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4\/ubiquitin-mediated pathway. Nat Cell Biol. 2008;10:547\u201355.","journal-title":"Nat Cell Biol"},{"key":"1789_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature16158","volume":"531","author":"C Bertolotto","year":"2016","unstructured":"Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M, Bille K, et al. Corrigendum: a SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature. 2016;531:126.","journal-title":"Nature"},{"key":"1789_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature10630","volume":"480","author":"S Yokoyama","year":"2011","unstructured":"Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature. 2011;480:99\u2013103.","journal-title":"Nature"},{"key":"1789_CR72","doi-asserted-by":"publisher","first-page":"e157644","DOI":"10.1172\/JCI157644","volume":"132","author":"Y Luo","year":"2022","unstructured":"Luo Y, Li Z, Kong Y, He W, Zheng H, An M, et al. KRAS mutant-driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. J Clin Investig. 2022;132:e157644.","journal-title":"J Clin Investig"},{"key":"1789_CR73","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","volume":"71","author":"S Kumar","year":"2022","unstructured":"Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, Sluijter M, Ruano D, et al. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 2022;71:2266\u201383.","journal-title":"Gut"},{"key":"1789_CR74","doi-asserted-by":"publisher","first-page":"e0013521","DOI":"10.1128\/MCB.00135-21","volume":"41","author":"S Rauth","year":"2021","unstructured":"Rauth S, Karmakar S, Shah A, Seshacharyulu P, Nimmakayala RK, Ganguly K, et al. SUMO modification of PAF1\/PD2 enables PML interaction and promotes radiation resistance in pancreatic ductal adenocarcinoma. Mol Cell Biol. 2021;41:e0013521.","journal-title":"Mol Cell Biol"},{"key":"1789_CR75","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1158\/0008-5472.CAN-20-2633","volume":"81","author":"F Arnold","year":"2021","unstructured":"Arnold F, Gout J, Wiese H, Weissinger SE, Roger E, Perkhofer L, et al. RINT1 regulates SUMOylation and the DNA damage response to preserve cellular homeostasis in pancreatic cancer. Cancer Res. 2021;81:1758\u201374.","journal-title":"Cancer Res"},{"key":"1789_CR76","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/pr401258d","volume":"13","author":"T Bonacci","year":"2014","unstructured":"Bonacci T, Audebert S, Camoin L, Baudelet E, Bidaut G, Garcia M, et al. Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins. J Proteome Res. 2014;13:2478\u201394.","journal-title":"J Proteome Res"},{"key":"1789_CR77","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1136\/gutjnl-2018-317856","volume":"69","author":"A Biederst\u00e4dt","year":"2020","unstructured":"Biederst\u00e4dt A, Hassan Z, Schneeweis C, Schick M, Schneider L, Muckenhuber A, et al. SUMO pathway inhibition targets an aggressive pancreatic cancer subtype. Gut. 2020;69:1472\u201382.","journal-title":"Gut"},{"key":"1789_CR78","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","volume":"39","author":"EL Deer","year":"2010","unstructured":"Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, et al. Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. Pancreas. 2010;39:425\u201335.","journal-title":"Pancreas"},{"key":"1789_CR79","first-page":"250","volume":"106","author":"AP Kyriazis","year":"1982","unstructured":"Kyriazis AP, Kyriazis AA, Scarpelli DG, Fogh J, Rao MS, Lepera R. Human pancreatic adenocarcinoma line Capan-1 in tissue culture and the nude mouse: morphologic, biologic, and biochemical characteristics. Am J Pathol. 1982;106:250\u201360.","journal-title":"Am J Pathol"},{"key":"1789_CR80","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ijc.2910150505","volume":"15","author":"M Lieber","year":"1975","unstructured":"Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer. 1975;15:741\u20137.","journal-title":"Int J Cancer"},{"key":"1789_CR81","first-page":"5810","volume":"46","author":"AA Kyriazis","year":"1986","unstructured":"Kyriazis AA, Kyriazis AP, Sternberg CN, Sloane NH, Loveless JD. Morphological, biological, biochemical, and karyotypic characteristics of human pancreatic ductal adenocarcinoma Capan-2 in tissue culture and the nude mouse. Cancer Res. 1986;46:5810\u20135.","journal-title":"Cancer Res"},{"key":"1789_CR82","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-23-1313","volume":"83","author":"KCM Gulay","year":"2023","unstructured":"Gulay KCM, Zhang X, Pantazopoulou V, Patel J, Esparza E, Pran Babu DS, et al. Dual inhibition of KRASG12D and Pan-ERBB is synergistic in pancreatic ductal adenocarcinoma. Cancer Res. 2023;83:3001\u201312.","journal-title":"Cancer Res"},{"key":"1789_CR83","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1158\/0008-5472.CAN-24-0744","volume":"85","author":"B Garg","year":"2025","unstructured":"Garg B, Khan S, Courelli AS, Panneerpandian P, Sheik Pran Babu D, Mose ES, et al. MICAL2 promotes pancreatic cancer growth and metastasis. Cancer Res. 2025;85:1049\u201363.","journal-title":"Cancer Res"},{"key":"1789_CR84","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/s43018-025-01003-3","volume":"6","author":"L Antonucci","year":"2025","unstructured":"Antonucci L, Li N, Duran A, Cobo I, Nicoletti C, Watari K, et al. Self-amplifying NRF2-EZH2 epigenetic loop converts KRAS-initiated progenitors to invasive pancreatic cancer. Nat Cancer. 2025;6:1263\u201382.","journal-title":"Nat Cancer"},{"key":"1789_CR85","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/sj.cdd.4401384","volume":"11","author":"YW Mao","year":"2004","unstructured":"Mao YW, Liu JP, Xiang H, Li DW. Human alphaA- and alphaB-crystallins bind to Bax and Bcl-X(S) to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 2004;11:512\u201326.","journal-title":"Cell Death Differ"},{"key":"1789_CR86","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/cdd.2010.16","volume":"17","author":"L Xiao","year":"2010","unstructured":"Xiao L, Gong LL, Yuan D, Deng M, Zeng XM, Chen LL, et al. Protein phosphatase-1 regulates Akt1signal transduction pathway to control gene expression, cell survival and differentiation. Cell Death Differ. 2010;17:1448\u201362.","journal-title":"Cell Death Differ"},{"key":"1789_CR87","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41418-022-00967-4","volume":"29","author":"M Zou","year":"2022","unstructured":"Zou M, Ke Q, Nie Q, Qi R, Zhu X, Liu W, et al. Inhibition of cGAS-STING by JQ1 alleviates oxidative stress-induced retina inflammation and degeneration. Cell Death Differ. 2022;29:1816\u201333.","journal-title":"Cell Death Differ"},{"key":"1789_CR88","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1158\/0008-5472.CAN-08-0839","volume":"68","author":"J Qin","year":"2008","unstructured":"Qin J, Chen HG, Yan Q, Deng M, Liu J, Doerge S, et al. Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates p53-Bak apoptotic pathway. Cancer Res. 2008;68:4150\u201362.","journal-title":"Cancer Res"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01789-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01789-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:02:54Z","timestamp":1782349374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01789-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":88,"alternative-id":["1789"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01789-4","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}